These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 34119127)
1. Azo modified hyaluronic acid based nanocapsules: CD44 targeted, UV-responsive decomposition and drug release in liver cancer cells. Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H Carbohydr Polym; 2021 Sep; 267():118152. PubMed ID: 34119127 [TBL] [Abstract][Full Text] [Related]
2. Layer-by-layer assembled decomposable nanocapsules for light-responsive release of pesticide imidacloprid on Aphis craccivora Koch. Gao Y; Xiao W; Gu C; Yu S; Li S; Zou A Pest Manag Sci; 2024 Jul; 80(7):3207-3214. PubMed ID: 38353377 [TBL] [Abstract][Full Text] [Related]
3. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy. Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019 [TBL] [Abstract][Full Text] [Related]
4. Near-Infrared Triggered Decomposition of Nanocapsules with High Tumor Accumulation and Stimuli Responsive Fast Elimination. Zhao T; Wang P; Li Q; Al-Khalaf AA; Hozzein WN; Zhang F; Li X; Zhao D Angew Chem Int Ed Engl; 2018 Mar; 57(10):2611-2615. PubMed ID: 29336520 [TBL] [Abstract][Full Text] [Related]
5. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery. Hang C; Zou Y; Zhong Y; Zhong Z; Meng F Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090 [TBL] [Abstract][Full Text] [Related]
6. Alginate-azo/chitosan nanocapsules in vitro drug delivery for hepatic carcinoma cells: UV-stimulated decomposition and drug release based on trans-to-cis isomerization. Chen Q; Li X; Xie Y; Hu W; Cheng Z; Zhong H; Zhu H Int J Biol Macromol; 2021 Sep; 187():214-222. PubMed ID: 34314790 [TBL] [Abstract][Full Text] [Related]
7. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690 [TBL] [Abstract][Full Text] [Related]
8. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery. Lin WJ; Lee WC Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822 [TBL] [Abstract][Full Text] [Related]
9. pH/H Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104 [TBL] [Abstract][Full Text] [Related]
10. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912 [TBL] [Abstract][Full Text] [Related]
11. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy. Sun CY; Zhang BB; Zhou JY J Mater Chem B; 2019 Aug; 7(31):4843-4853. PubMed ID: 31389968 [TBL] [Abstract][Full Text] [Related]
12. Stabilized, ROS-sensitive β-cyclodextrin-grafted hyaluronic supramolecular nanocontainers for CD44-targeted anticancer drug delivery. Zhang X; Wang P; Wang X; Xu Y; Cheng T; Zhang C; Ding J; Shi Y; Ma W; Yu CY; Wei H Colloids Surf B Biointerfaces; 2024 Oct; 242():114081. PubMed ID: 39003850 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy. Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163 [TBL] [Abstract][Full Text] [Related]
14. A photo-controlled hyaluronan-based drug delivery nanosystem for cancer therapy. Sun F; Zhang P; Liu Y; Lu C; Qiu Y; Mu H; Duan J Carbohydr Polym; 2019 Feb; 206():309-318. PubMed ID: 30553327 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin. Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383 [TBL] [Abstract][Full Text] [Related]
16. Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures. El-Dakdouki MH; Puré E; Huang X Nanoscale; 2013 May; 5(9):3895-903. PubMed ID: 23529646 [TBL] [Abstract][Full Text] [Related]
17. ROS-initiated chemiluminescence-driven payload release from macrocycle-based Azo-containing polymer nanocapsules. Sun C; Wang Z; Yue L; Huang Q; Lu S; Wang R J Mater Chem B; 2020 Oct; 8(38):8878-8883. PubMed ID: 33026388 [TBL] [Abstract][Full Text] [Related]
18. On-Demand Antimicrobial Agent Release from Functionalized Conjugated Oligomer-Hyaluronic Acid Nanoparticles for Tackling Antimicrobial Resistance. Yuan Q; Zhao Y; Zhang Z; Tang Y ACS Appl Mater Interfaces; 2021 Jan; 13(1):257-265. PubMed ID: 33378174 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery. Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914 [TBL] [Abstract][Full Text] [Related]
20. A DNA-Azobenzene Nanopump Fueled by Upconversion Luminescence for Controllable Intracellular Drug Release. Zhang Y; Zhang Y; Song G; He Y; Zhang X; Liu Y; Ju H Angew Chem Int Ed Engl; 2019 Dec; 58(50):18207-18211. PubMed ID: 31583799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]